Heart failure (HF) describes a heterogenous complex spectrum of pathological conditions
that results in structural and functional remodeling leading to subsequent impairment of …

Cardiogenic shock (CS) in acute coronary syndrome (ACS) is a critical disease with high
mortality rates requiring complex treatment to maximize patient survival chances. Emergent …

Not much is known about the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i)
on echocardiographic parameters of left ventricular (LV) systolic function in patients with …

Background The left ventricular ejection fraction (LVEF) is the most commonly used measure
describing pumping efficiency, but it is heavily dependent on loading conditions and …

Aims Volume overload (VO) induced hypertrophy is one of the hallmarks to the development
of heart diseases. Understanding the compensatory mechanisms involved in this process …

Purpose This study is to assess the diagnostic value of noninvasive regional myocardial
work (MW) by echocardiography for detecting the functional status of coronary stenosis …

Concentric LV remodeling and hypertrophy are common structural abnormalities in patients
with heart failure with preserved ejection fraction (HFpEF) and tend to be accompanied by …

Purpose To assess the correlation between noninvasive cardiac MRI–derived parameters
with pressure-volume (PV) loop data and evaluate changes in left ventricular function after …

Objective Myocardial fibrosis leads to systolic dysfunction in hypertrophic cardiomyopathy
(HCM) patients. This study aims to investigate the relationship between cardiac magnetic …

Myocardial sodium-glucose cotransporter 1 (SGLT1) has been shown to be upregulated in
humans with heart failure (HF) with or without diabetes. In vitro studies have linked SGLT1 to …